Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.40 USD
Change Today -0.04 / -1.64%
Volume 100.3K
FHCO On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

female health company (FHCO) Snapshot

Open
$2.42
Previous Close
$2.44
Day High
$2.42
Day Low
$2.38
52 Week High
05/27/14 - $6.05
52 Week Low
05/26/15 - $2.38
Market Cap
69.2M
Average Volume 10 Days
97.4K
EPS TTM
$0.11
Shares Outstanding
28.8M
EX-Date
07/14/14
P/E TM
21.8x
Dividend
--
Dividend Yield
2.92%
Current Stock Chart for FEMALE HEALTH COMPANY (FHCO)

female health company (FHCO) Related Bloomberg News

View More Bloomberg News

female health company (FHCO) Related Businessweek News

No Related Businessweek News Found

female health company (FHCO) Details

The Female Health Company develops, manufactures, and markets consumer health care products. It offers the FC2 female condom that provides women dual protection against unintended pregnancy and sexually transmitted infections, including HIV/AIDS. The company sells its products to global agencies, non-government organizations, ministries of health, and other government agencies directly, as well as through distribution agreements and other arrangements with commercial partners. It operates in South Africa, Angola, Brazil, Uganda, Nigeria, Zimbabwe, Tanzania, the United States, Brazil, Malaysia, the Democratic Republic of the Congo, and internationally. The company was founded in 1896 and is headquartered in Chicago, Illinois.

149 Employees
Last Reported Date: 12/2/14
Founded in 1896

female health company (FHCO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $245.5K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $207.5K
Executive Vice President of Sales and Marketi...
Total Annual Compensation: $101.4K
Compensation as of Fiscal Year 2014.

female health company (FHCO) Key Developments

The Female Health Company Appoints Andrew S. Love as New Member of Audit Committee

The Female Health Company announced that the board of directors approved the appointment of Andrew S. Love, an existing independent director, as a new member of the Audit Committee with immediate effect.

The Female Health Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2015

The Female Health Company announced unaudited consolidated earnings results for the second quarter and six months ended March 31, 2015. For the quarter, the company's net revenues were $10,977,467 compared with $4,346,223 a year ago. Operating income was $2,949,393 compared with $795,223 a year ago. The increase was primarily due to increased net revenues and improved gross margins, partially offset by higher operating expenses. Income before income taxes was $2,974,019 compared with $879,979 a year ago. Net income was $1,667,574 or $0.06 per basic and diluted share compared with $375,081 or $0.01 per basic and diluted share a year ago. Adjusted EBITDA was $3,276,206 compared with $1,222,068 a year ago. Diluted earnings per share, as adjusted were $0.11 compared with $0.04 a year ago. For the six months, the company's net revenues were $17,636,673 compared with $11,036,418 a year ago. Operating income was $4,403,242 compared with $2,378,859 a year ago. The increase was primarily due to higher net revenues and improved gross margins partially offset by higher operating expenses. Income before income taxes was $4,449,366 compared with $2,443,457 a year ago. Net income was $2,472,491 or $0.09 per basic and diluted share compared with $1,839,684 or $0.06 per basic and diluted share a year ago. Net cash used in operating activities was $2,829,233 compared with net cash provided by operating activities of $1,165,876 a year ago. Adjusted EBITDA was $5,078,516 compared with $3,132,320 a year ago. Diluted earnings per share, as adjusted were $0.18 compared with $0.11 a year ago.

The Female Health Company Presents at 16th Annual B. Riley & Co. Investor Conference, May-12-2015 09:00 AM

The Female Health Company Presents at 16th Annual B. Riley & Co. Investor Conference, May-12-2015 09:00 AM. Venue: Loews Hollywood Hotel, Los Angeles, California, United States. Speakers: Karen L. King, Chief Executive Officer, President and Director, Michele Greco, Chief Financial Officer and Executive Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FHCO:US $2.40 USD -0.04

FHCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FHCO.
View Industry Companies
 

Industry Analysis

FHCO

Industry Average

Valuation FHCO Industry Range
Price/Earnings 22.9x
Price/Sales 2.2x
Price/Book 2.3x
Price/Cash Flow 22.9x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FEMALE HEALTH COMPANY, please visit www.femalehealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.